0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biopharmaceutical Third-party Logistics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-8C6111
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical Third Party Logistics Market Insights and Forecast to 2028
BUY CHAPTERS

Biopharmaceutical Third-party Logistics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-8C6111
Report
October 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharmaceutical Third-party Logistics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical Third-party Logistics - Market

Biopharmaceutical Third-party Logistics - Market

The global market for Biopharmaceutical Third-party Logistics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Third-party Logistics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Third-party Logistics by region & country, by Type, and by Application.
The Biopharmaceutical Third-party Logistics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Third-party Logistics.
Market Segmentation

Scope of Biopharmaceutical Third-party Logistics - Market Report

Report Metric Details
Report Name Biopharmaceutical Third-party Logistics - Market
CAGR 5%
Segment by Type:
  • Cold Chain
  • Non-cold Chain
Segment by Application
  • Transportation
  • Storage
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company DHL International GmbH, SF Express, United Parcel Service of America, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry Logistics Network, Agility Logistics, McKesson Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biopharmaceutical Third-party Logistics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biopharmaceutical Third-party Logistics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biopharmaceutical Third-party Logistics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Biopharmaceutical Third-party Logistics - Market report?

Ans: The main players in the Biopharmaceutical Third-party Logistics - Market are DHL International GmbH, SF Express, United Parcel Service of America, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry Logistics Network, Agility Logistics, McKesson Corporation

What are the Application segmentation covered in the Biopharmaceutical Third-party Logistics - Market report?

Ans: The Applications covered in the Biopharmaceutical Third-party Logistics - Market report are Transportation, Storage, Other

What are the Type segmentation covered in the Biopharmaceutical Third-party Logistics - Market report?

Ans: The Types covered in the Biopharmaceutical Third-party Logistics - Market report are Cold Chain, Non-cold Chain

1 Market Overview
1.1 Biopharmaceutical Third-party Logistics Product Introduction
1.2 Global Biopharmaceutical Third-party Logistics Market Size Forecast
1.3 Biopharmaceutical Third-party Logistics Market Trends & Drivers
1.3.1 Biopharmaceutical Third-party Logistics Industry Trends
1.3.2 Biopharmaceutical Third-party Logistics Market Drivers & Opportunity
1.3.3 Biopharmaceutical Third-party Logistics Market Challenges
1.3.4 Biopharmaceutical Third-party Logistics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Third-party Logistics Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Third-party Logistics Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Third-party Logistics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Third-party Logistics Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Third-party Logistics
2.6 Biopharmaceutical Third-party Logistics Market Competitive Analysis
2.6.1 Biopharmaceutical Third-party Logistics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Third-party Logistics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Third-party Logistics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cold Chain
3.1.2 Non-cold Chain
3.2 Global Biopharmaceutical Third-party Logistics Sales Value by Type
3.2.1 Global Biopharmaceutical Third-party Logistics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Third-party Logistics Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Third-party Logistics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Transportation
4.1.2 Storage
4.1.3 Other
4.2 Global Biopharmaceutical Third-party Logistics Sales Value by Application
4.2.1 Global Biopharmaceutical Third-party Logistics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Third-party Logistics Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Third-party Logistics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Third-party Logistics Sales Value by Region
5.1.1 Global Biopharmaceutical Third-party Logistics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Third-party Logistics Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Third-party Logistics Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Third-party Logistics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Third-party Logistics Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Third-party Logistics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DHL International GmbH
7.1.1 DHL International GmbH Profile
7.1.2 DHL International GmbH Main Business
7.1.3 DHL International GmbH Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.1.4 DHL International GmbH Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.1.5 DHL International GmbH Recent Developments
7.2 SF Express
7.2.1 SF Express Profile
7.2.2 SF Express Main Business
7.2.3 SF Express Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.2.4 SF Express Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.2.5 SF Express Recent Developments
7.3 United Parcel Service of America
7.3.1 United Parcel Service of America Profile
7.3.2 United Parcel Service of America Main Business
7.3.3 United Parcel Service of America Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.3.4 United Parcel Service of America Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.3.5 AmerisourceBergen Corporation Recent Developments
7.4 AmerisourceBergen Corporation
7.4.1 AmerisourceBergen Corporation Profile
7.4.2 AmerisourceBergen Corporation Main Business
7.4.3 AmerisourceBergen Corporation Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.4.4 AmerisourceBergen Corporation Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.4.5 AmerisourceBergen Corporation Recent Developments
7.5 DB Schenker
7.5.1 DB Schenker Profile
7.5.2 DB Schenker Main Business
7.5.3 DB Schenker Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.5.4 DB Schenker Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.5.5 DB Schenker Recent Developments
7.6 Kuehne and Nagel
7.6.1 Kuehne and Nagel Profile
7.6.2 Kuehne and Nagel Main Business
7.6.3 Kuehne and Nagel Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.6.4 Kuehne and Nagel Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.6.5 Kuehne and Nagel Recent Developments
7.7 Kerry Logistics Network
7.7.1 Kerry Logistics Network Profile
7.7.2 Kerry Logistics Network Main Business
7.7.3 Kerry Logistics Network Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.7.4 Kerry Logistics Network Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.7.5 Kerry Logistics Network Recent Developments
7.8 Agility Logistics
7.8.1 Agility Logistics Profile
7.8.2 Agility Logistics Main Business
7.8.3 Agility Logistics Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.8.4 Agility Logistics Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.8.5 Agility Logistics Recent Developments
7.9 McKesson Corporation
7.9.1 McKesson Corporation Profile
7.9.2 McKesson Corporation Main Business
7.9.3 McKesson Corporation Biopharmaceutical Third-party Logistics Products, Services and Solutions
7.9.4 McKesson Corporation Biopharmaceutical Third-party Logistics Revenue (US$ Million) & (2019-2024)
7.9.5 McKesson Corporation Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Third-party Logistics Industrial Chain
8.2 Biopharmaceutical Third-party Logistics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Third-party Logistics Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Third-party Logistics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Biopharmaceutical Third-party Logistics Market Trends
    Table 2. Biopharmaceutical Third-party Logistics Market Drivers & Opportunity
    Table 3. Biopharmaceutical Third-party Logistics Market Challenges
    Table 4. Biopharmaceutical Third-party Logistics Market Restraints
    Table 5. Global Biopharmaceutical Third-party Logistics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biopharmaceutical Third-party Logistics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Biopharmaceutical Third-party Logistics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Biopharmaceutical Third-party Logistics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical Third-party Logistics
    Table 10. Global Biopharmaceutical Third-party Logistics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Third-party Logistics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Biopharmaceutical Third-party Logistics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Biopharmaceutical Third-party Logistics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Biopharmaceutical Third-party Logistics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Biopharmaceutical Third-party Logistics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Biopharmaceutical Third-party Logistics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Biopharmaceutical Third-party Logistics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Biopharmaceutical Third-party Logistics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Biopharmaceutical Third-party Logistics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Biopharmaceutical Third-party Logistics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Biopharmaceutical Third-party Logistics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Biopharmaceutical Third-party Logistics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Biopharmaceutical Third-party Logistics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Biopharmaceutical Third-party Logistics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Biopharmaceutical Third-party Logistics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Biopharmaceutical Third-party Logistics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value, (2025-2030) & (US$ Million)
    Table 31. DHL International GmbH Basic Information List
    Table 32. DHL International GmbH Description and Business Overview
    Table 33. DHL International GmbH Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of DHL International GmbH (2019-2024)
    Table 35. DHL International GmbH Recent Developments
    Table 36. SF Express Basic Information List
    Table 37. SF Express Description and Business Overview
    Table 38. SF Express Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of SF Express (2019-2024)
    Table 40. SF Express Recent Developments
    Table 41. United Parcel Service of America Basic Information List
    Table 42. United Parcel Service of America Description and Business Overview
    Table 43. United Parcel Service of America Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of United Parcel Service of America (2019-2024)
    Table 45. United Parcel Service of America Recent Developments
    Table 46. AmerisourceBergen Corporation Basic Information List
    Table 47. AmerisourceBergen Corporation Description and Business Overview
    Table 48. AmerisourceBergen Corporation Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of AmerisourceBergen Corporation (2019-2024)
    Table 50. AmerisourceBergen Corporation Recent Developments
    Table 51. DB Schenker Basic Information List
    Table 52. DB Schenker Description and Business Overview
    Table 53. DB Schenker Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of DB Schenker (2019-2024)
    Table 55. DB Schenker Recent Developments
    Table 56. Kuehne and Nagel Basic Information List
    Table 57. Kuehne and Nagel Description and Business Overview
    Table 58. Kuehne and Nagel Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of Kuehne and Nagel (2019-2024)
    Table 60. Kuehne and Nagel Recent Developments
    Table 61. Kerry Logistics Network Basic Information List
    Table 62. Kerry Logistics Network Description and Business Overview
    Table 63. Kerry Logistics Network Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of Kerry Logistics Network (2019-2024)
    Table 65. Kerry Logistics Network Recent Developments
    Table 66. Agility Logistics Basic Information List
    Table 67. Agility Logistics Description and Business Overview
    Table 68. Agility Logistics Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of Agility Logistics (2019-2024)
    Table 70. Agility Logistics Recent Developments
    Table 71. McKesson Corporation Basic Information List
    Table 72. McKesson Corporation Description and Business Overview
    Table 73. McKesson Corporation Biopharmaceutical Third-party Logistics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Biopharmaceutical Third-party Logistics Business of McKesson Corporation (2019-2024)
    Table 75. McKesson Corporation Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Biopharmaceutical Third-party Logistics Downstream Customers
    Table 79. Biopharmaceutical Third-party Logistics Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Biopharmaceutical Third-party Logistics Product Picture
    Figure 2. Global Biopharmaceutical Third-party Logistics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biopharmaceutical Third-party Logistics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Biopharmaceutical Third-party Logistics Report Years Considered
    Figure 5. Global Biopharmaceutical Third-party Logistics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical Third-party Logistics Revenue in 2023
    Figure 7. Biopharmaceutical Third-party Logistics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Cold Chain Picture
    Figure 9. Non-cold Chain Picture
    Figure 10. Global Biopharmaceutical Third-party Logistics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Biopharmaceutical Third-party Logistics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Transportation
    Figure 13. Product Picture of Storage
    Figure 14. Product Picture of Other
    Figure 15. Global Biopharmaceutical Third-party Logistics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Biopharmaceutical Third-party Logistics Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Biopharmaceutical Third-party Logistics Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Biopharmaceutical Third-party Logistics Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Biopharmaceutical Third-party Logistics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Biopharmaceutical Third-party Logistics Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Biopharmaceutical Third-party Logistics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Biopharmaceutical Third-party Logistics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Biopharmaceutical Third-party Logistics Sales Value (%), (2019-2030)
    Figure 28. United States Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Biopharmaceutical Third-party Logistics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Biopharmaceutical Third-party Logistics Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Biopharmaceutical Third-party Logistics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Biopharmaceutical Third-party Logistics Industrial Chain
    Figure 50. Biopharmaceutical Third-party Logistics Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS